Nucleic Acid Vaccine:A Nucleic Acid Vaccine is a type of vaccine that uses genetic material, such as DNA or RNA, to stimulate an immune response. It offers a novel approach to vaccine development.
The global Nucleic Acid Vaccine market is projected to grow from US$ 52790 million in 2024 to US$ 61580 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period.
The market for Nucleic Acid Vaccines has gained prominence with advancements in biotechnology. Trends include ongoing research on mRNA vaccines, development of vaccines for emerging diseases, and the potential for personalized vaccination strategies.
Report Covers:
This report presents an overview of global market for Nucleic Acid Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Nucleic Acid Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nucleic Acid Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Nucleic Acid Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Nucleic Acid Vaccine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
Segment by Type
Preventive Nucleic Acid Vaccine
Therapeutic Vucleic Acid Vaccine
Segment by Application
Hospital
Clinic
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Nucleic Acid Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Nucleic Acid Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Nucleic Acid Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Nucleic Acid Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Preventive Nucleic Acid Vaccine
1.2.3 Therapeutic Vucleic Acid Vaccine
1.3 Market by Application
1.3.1 Global Nucleic Acid Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nucleic Acid Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Nucleic Acid Vaccine Revenue by Region
2.2.1 Global Nucleic Acid Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Nucleic Acid Vaccine Revenue by Region (2019-2024)
2.2.3 Global Nucleic Acid Vaccine Revenue by Region (2025-2030)
2.2.4 Global Nucleic Acid Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global Nucleic Acid Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Nucleic Acid Vaccine Sales by Region
2.4.1 Global Nucleic Acid Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Nucleic Acid Vaccine Sales by Region (2019-2024)
2.4.3 Global Nucleic Acid Vaccine Sales by Region (2025-2030)
2.4.4 Global Nucleic Acid Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Nucleic Acid Vaccine Sales by Manufacturers
3.1.1 Global Nucleic Acid Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Nucleic Acid Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nucleic Acid Vaccine in 2023
3.2 Global Nucleic Acid Vaccine Revenue by Manufacturers
3.2.1 Global Nucleic Acid Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Nucleic Acid Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Nucleic Acid Vaccine Revenue in 2023
3.3 Global Key Players of Nucleic Acid Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Nucleic Acid Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Nucleic Acid Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Nucleic Acid Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Nucleic Acid Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Nucleic Acid Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nucleic Acid Vaccine Sales by Type
4.1.1 Global Nucleic Acid Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Nucleic Acid Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Nucleic Acid Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Nucleic Acid Vaccine Revenue by Type
4.2.1 Global Nucleic Acid Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Nucleic Acid Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Nucleic Acid Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Nucleic Acid Vaccine Price by Type
4.3.1 Global Nucleic Acid Vaccine Price by Type (2019-2024)
4.3.2 Global Nucleic Acid Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Nucleic Acid Vaccine Sales by Application
5.1.1 Global Nucleic Acid Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Nucleic Acid Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Nucleic Acid Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Nucleic Acid Vaccine Revenue by Application
5.2.1 Global Nucleic Acid Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Nucleic Acid Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Nucleic Acid Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Nucleic Acid Vaccine Price by Application
5.3.1 Global Nucleic Acid Vaccine Price by Application (2019-2024)
5.3.2 Global Nucleic Acid Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Nucleic Acid Vaccine Market Size by Type
6.1.1 US & Canada Nucleic Acid Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Nucleic Acid Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Nucleic Acid Vaccine Market Size by Application
6.2.1 US & Canada Nucleic Acid Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Nucleic Acid Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Nucleic Acid Vaccine Market Size by Country
6.3.1 US & Canada Nucleic Acid Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Nucleic Acid Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Nucleic Acid Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Nucleic Acid Vaccine Market Size by Type
7.1.1 Europe Nucleic Acid Vaccine Sales by Type (2019-2030)
7.1.2 Europe Nucleic Acid Vaccine Revenue by Type (2019-2030)
7.2 Europe Nucleic Acid Vaccine Market Size by Application
7.2.1 Europe Nucleic Acid Vaccine Sales by Application (2019-2030)
7.2.2 Europe Nucleic Acid Vaccine Revenue by Application (2019-2030)
7.3 Europe Nucleic Acid Vaccine Market Size by Country
7.3.1 Europe Nucleic Acid Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Nucleic Acid Vaccine Sales by Country (2019-2030)
7.3.3 Europe Nucleic Acid Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Nucleic Acid Vaccine Market Size
8.1.1 China Nucleic Acid Vaccine Sales (2019-2030)
8.1.2 China Nucleic Acid Vaccine Revenue (2019-2030)
8.2 China Nucleic Acid Vaccine Market Size by Application
8.2.1 China Nucleic Acid Vaccine Sales by Application (2019-2030)
8.2.2 China Nucleic Acid Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Nucleic Acid Vaccine Market Size by Type
9.1.1 Asia Nucleic Acid Vaccine Sales by Type (2019-2030)
9.1.2 Asia Nucleic Acid Vaccine Revenue by Type (2019-2030)
9.2 Asia Nucleic Acid Vaccine Market Size by Application
9.2.1 Asia Nucleic Acid Vaccine Sales by Application (2019-2030)
9.2.2 Asia Nucleic Acid Vaccine Revenue by Application (2019-2030)
9.3 Asia Nucleic Acid Vaccine Sales by Region
9.3.1 Asia Nucleic Acid Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Nucleic Acid Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Nucleic Acid Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Nucleic Acid Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Nucleic Acid Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Nucleic Acid Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Nucleic Acid Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Nucleic Acid Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Nucleic Acid Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Nucleic Acid Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Nucleic Acid Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Nucleic Acid Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Nucleic Acid Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Moderna
11.1.1 Moderna Company Information
11.1.2 Moderna Overview
11.1.3 Moderna Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Moderna Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Recent Developments
11.2 CureVac
11.2.1 CureVac Company Information
11.2.2 CureVac Overview
11.2.3 CureVac Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 CureVac Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Inovio
11.3.1 Inovio Company Information
11.3.2 Inovio Overview
11.3.3 Inovio Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Inovio Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Inovio Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sanofi Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Overview
11.5.3 GSK Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GSK Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 CNBG
11.6.1 CNBG Company Information
11.6.2 CNBG Overview
11.6.3 CNBG Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 CNBG Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CNBG Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Company Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hualan Bio Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Bio Recent Developments
11.8 Zhifei Shengwu
11.8.1 Zhifei Shengwu Company Information
11.8.2 Zhifei Shengwu Overview
11.8.3 Zhifei Shengwu Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Zhifei Shengwu Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhifei Shengwu Recent Developments
11.9 Liaoning Chengda
11.9.1 Liaoning Chengda Company Information
11.9.2 Liaoning Chengda Overview
11.9.3 Liaoning Chengda Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Liaoning Chengda Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Liaoning Chengda Recent Developments
11.10 BioKangtai
11.10.1 BioKangtai Company Information
11.10.2 BioKangtai Overview
11.10.3 BioKangtai Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 BioKangtai Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BioKangtai Recent Developments
11.11 CanSinoBIO
11.11.1 CanSinoBIO Company Information
11.11.2 CanSinoBIO Overview
11.11.3 CanSinoBIO Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 CanSinoBIO Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CanSinoBIO Recent Developments
11.12 Walvax Biotechnology
11.12.1 Walvax Biotechnology Company Information
11.12.2 Walvax Biotechnology Overview
11.12.3 Walvax Biotechnology Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Walvax Biotechnology Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Walvax Biotechnology Recent Developments
11.13 Fosun Pharma
11.13.1 Fosun Pharma Company Information
11.13.2 Fosun Pharma Overview
11.13.3 Fosun Pharma Nucleic Acid Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Fosun Pharma Nucleic Acid Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Fosun Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nucleic Acid Vaccine Industry Chain Analysis
12.2 Nucleic Acid Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nucleic Acid Vaccine Production Mode & Process
12.4 Nucleic Acid Vaccine Sales and Marketing
12.4.1 Nucleic Acid Vaccine Sales Channels
12.4.2 Nucleic Acid Vaccine Distributors
12.5 Nucleic Acid Vaccine Customers
13 Market Dynamics
13.1 Nucleic Acid Vaccine Industry Trends
13.2 Nucleic Acid Vaccine Market Drivers
13.3 Nucleic Acid Vaccine Market Challenges
13.4 Nucleic Acid Vaccine Market Restraints
14 Key Findings in The Global Nucleic Acid Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Moderna
CureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
听
听
*If Applicable.